*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *NUOVA CURA 'AFFAMA' CELLULE NEL CERVELLO E NE BLOCCA CRESCITA* * * *18 March 2009* * * Parte da Bologna...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Brain cancer linked to youngsters using cellphones* * * *1**7 March 2009* * * An international group of...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Antigenics’ Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer* * * ...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Is my chemo working? Scans may give faster answer* * * *4 March 2009* * * When Mike Stevens learned his...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Independent association of extent of resection with survival in patients with malignant brain astrocytoma ...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Gene May Lead To Early Onset Of Brain Tumor* * * *27 January 2009* * * People with a particular gene...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Cilengitide: Does It Really Represent a New Targeted Therapy for Recurrent Glioblastoma?* * * *2...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Occupational exposure to magnetic fields and the risk of brain tumors* * * *20 February** 2009* * * ...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Birth month and risk of glioma in adults: a registry-based study in Bavaria* * * *26 February** 2009* *...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Maternal occupational exposure to extremely low frequency magnetic fields and the risk of brain cancer...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells* * * ...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression* * * *17...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma* * *...
*THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/>* *Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Recurrence Pattern after Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. 3 February...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Improbabili i tumori causati da cellulari 5 February 2009 Alla luce delle conoscenze scientifiche attuali...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Tumori al cervello, a Lecce nuova tecnica d'intervento 27 February 2009 La filosofia è simile a quella...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Svelato il segreto della protezione dal Cancro 2 February 2009 Scienziati dell'Università di Dundee...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Ark wins French approval for named patient supply of cancer drug 19 February 2009 Ark Therapeutics, a...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it/> Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for the Prime Time...